FATHIMA CHOWDHURY: Open Payments
NPI 1760823132 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$23,455 in 68 payments from 10 companies in 2025. Trend: 2023 $2,996 · 2024 $46,170 · 2025 $23,455
Speaker / faculty: $20,668Travel & lodging: $1,550Food & beverage: $1,237
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 41 | $22,828 |
| Otsuka America Pharmaceutical, Inc. | 10 | $262 |
| E.R. Squibb & Sons, L.L.C. | 4 | $107 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Lundbeck LLC | 2 | $34 |
| Indivior Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: SPRAVATO, REXULTI, COBENFY, Auvelity, ABILIFY ASIMTUFII, CAPLYTA, SUBLOCADE, VRAYLAR.
Industry payments across TX — which companies pay providers there.
